Podcasts about XXXX

The US and Iran have agreed to a truce and are expected to sign a preliminary agreement in Geneva later this week. Oil prices have eased, markets have rallied and fears over disruptions through the Strait of Hormuz have receded. In #CutTheClutter episode XXXX, ThePrint Editor-in-Chief Shekhar Gupta breaks down the emerging Iran-US truce in 10 points, decoding the significance of the understanding, Pakistan's role in the diplomatic process, why Israel is unhappy with the outcome, what it means for the Gulf Arab states, and why the peace dividend is of enormous significance for India.----more----Read The Washington Post's article here: https://www.washingtonpost.com/world/2026/06/12/qatar-pursued-secret-talks-with-iran-shield-gas-complex-strikes/----more----Read Barak Ravid's article here: https://www.axios.com/2026/06/14/trump-netanyahu-iran-deal-israel-beirut-strike----more----Watch 'Syria, Turkey, Kurds, ISIS, Trump & Putin, & how Middle East unravelled in murderous chaos | ep 294' here: https://youtu.be/mwKDHWXdIBc

Today on Beating Cancer Daily, Saranne welcomes back one of her favorite people, comedian Missy Hall, for their 49th episode together. Missy brings her unique comedic perspective to her journey with Stage IV cancer, which she initially shared with Saranne after being diagnosed. Their conversation today highlights the joys, challenges, and humor of the cancer journey, and they celebrate the emotional milestone of this ongoing shared experience, which has reached audiences in 99 countries.2025 People's Choice Podcast Awards Best Health Series FinalistRanked the Top 5 Best Cancer Podcasts by CancerCare News in 2024 & 2025,and #1 Rated Cancer Survivor Podcast by FeedSpot in 2024 to 2025. Beating Cancer Daily is listened to in 148 countries across 7 continents and features over 420+ original daily episodes hosted by Stage IV survivor Saranne Rothberg. To learn more about Host Saranne Rothberg and The ComedyCures Foundation:https://www.comedycures.org/ To write to Saranne or a guest:https://www.comedycures.org/contact-8 To record a message to Saranne or a guest:https://www.speakpipe.com/BCD_Comments_Suggestions To sign up for the free Health Builder Series live on Zoom with Saranne and Jacqui, go to The ComedyCures Foundation's homepage:https://www.comedycures.org/ Please support the creation of more original episodes of Beating Cancer Daily and other free ComedyCures Foundation programs with a tax-deductible contribution:http://bit.ly/ComedyCuresDonate THANK YOU! Please tell a friend whom we may help, and please support us with a beautiful review. Have a blessed day! Saranne

"This piece takes the original recording and focuses on the relationship between destructive extraction and a tiny town in the hills, surrounded by lush mountains, deep caves, and amazing waterfalls. The hills are alive but no longer untouched. Star Cement is slowly trudging through the Jaintia hills. The enormous foreboding lights can be seen from the single-road village while the singing drifts through the natural nighttime chorus."XXXX reimagined by wwjd.

It’s Knock Off Friday, and listeners pile in to share when they’re clocking off, scoring big with XXXX prizes and Vienetta 6‑packs as the final slabs vanish fast. Pats is outed as the Team Traitor after a sneaky solo McDonald’s run, prompting Christian to shout the rest of the team Macca's. We also meet a wildlife sanctuary caring for retired circus animals - including two psychic tigers now predicting the World Cup for us, before wrapping with Disney Bands for At Work Time Wasters. See omnystudio.com/listener for privacy information.

This week Bomb The Algorithm stopped by the studio and had a great chat with us about . what the XXXX is going on as well as some stories of their music, lyrics and musical journey. It isn't an easy time my friends. Be excellent to each other x can be found at the following links: Instagram: https://www.instagram.com/bombthealgorithm Enjoy their music on Spotify, or you can find them on the new 561 Music Playlist we created of various local artists that we will be continually updating. on Spotify: https://open.spotify.com/artist/7jPPffDhnGDpajPLfTtEOC?si=9xINO122RZaObp6jJ_uziA 561 Music Playlist: https://open.spotify.com/playlist/7y2i0AgJTGRMtxMADgZ7AZ?si=Zp77sq_BTue_wWTDouxH2g 561 Music Links: Facebook: https://www.facebook.com/561musicpodcast Instagram: https://www.instagram.com/561musicpodcast Twitter: https://twitter.com/561musicpodcast YouTube: https://www.youtube.com/c/561musicpodcast A huge thank you to our sponsors this week. JUPITER INLET BOAT RENTALS Jupiter Inlet Boat Rentals is Palm Beach County's Premier Boat Rental Company and Boat Rental Club. As an alternative to boat ownership, our membership club ranks number #1 in boat quality, availability and customer satisfaction. OASIS ROOT COFFEE AND KAVA LOUNGE Oasis Root Coffee and Kava Lounge in Jupiter is a fun, relaxing place to come by drink kava, java, or tea, and hang out… South Pacific Style! Open daily from 8am-1am. Located at 185 E. Indiantown Rd., Suite 111, Jupiter, FL 33477. 561 MUSIC SCHOOL AND STUDIO Thank you to Justin and 561 MUSIC SCHOOL AND STUDIO for all they do to make our podcasts as professional as possible. If you are looking to do a podcast, record an album, do a live stream, or anything of that type, Live Music Community is the place to go. 561 MUSIC SCHOOL AND STUDIO is also a music school that takes it up a notch by not only teaching the foundations of music theory and songs on instruments and vocals but also teaches the students the full band experience. They team your child up with like-minded individuals who then go on to play shows, do live streams, and learn the dos and don'ts of being in a successful working band. You can find them online at https://www.561musicstudio.com and on Facebook and Instagram. 561 Music Podcast was recorded by our producer Justin Hucker at 561 Music School and Studio, which offers podcasting, video production, live stream, music lessons, recording and so much more. Check them out and take a virtual studio tour here: Thank you to Justin and 561 MUSIC SCHOOL AND STUDIO for all they do to make our podcasts as professional as possible. If you are looking to do a podcast, record an album, do a live stream, or anything of that type, Live Music Community is the place to go. 561 MUSIC SCHOOL AND STUDIO is also a music school that takes it up a notch by not only teaching the foundations of music theory and songs on instruments and vocals but also teaches the students the full band experience. They team your child up with like-minded individuals who then go on to play shows, do live streams, and learn the dos and don'ts of being in a successful working band. You can find them online at https://www.561musicstudio.com and on Facebook and Instagram.

While driving his BMW Bauer, he was discovered as a fashion model, which enabled him to pursue his eccentric lifestyle – from his London Motor Museum, featuring Mr. Bean's Mini and the Rolls-Royce “Bootch”, to his Supercar Rooms Miami, where guests can dine with their cars, and finally to his next goal: to make it legally possible to even marry your own car.Discover more and follow us:

Send us Fan MailOur Patreon - https://www.patreon.com/HockeyCardsGongshowOn this episode of the Hockey Cards Gongshow podcast we start with Get To Know Your Hockey Hall of Famers, this time looking at the life, hockey career, and hobby market for hockey hall of famer, Alex Delvecchio (13:42). Next, in the Weekly 7: we preview the upcoming Stanley Cup Finals matchup and talk potential hobby impact, take a look at playoff scoring leaders, review potential Summer trade targets, Celebrini shines at the World Championships, and RIP Claude Lemieux (29:56).  In hobby news, PSA suspends value service levels and another key Gretzky game used jersey goes to auction (1:25:59).  We have a major hockey release this week with 2025-26 Extended Series and we preview the checklist and key card designs (1:46:03).  Next, we answer your hockey cards mailbag questions (XX:XX), then end the show with personal pickups (XX:XX).Partners & SponsorsThe Upper Deck Company - https://www.UpperDeck.comGongshow Breaks - https://wwwGongshowBreaks.comGongshow Reloaded - https://www.GongshowReloaded.comHockeyChecklists.com - https://www.hockeychecklists.comSlab Sharks Consignment - http://bit.ly/3GUvsxNSlab Sharks is now accepting U.S. submissions!GP Sports Cards - https://gpsportcards.com/Total Sports Cards - https://totalsportcards.comSign up for Card Ladder - https://app.cardladder.com/signup?via=HCGongshoFollow Hockey Cards Gongshow on social mediaInstagram - https://www.instagram.com/hockey_cards_gongshow/TikTok - https://www.tiktok.com/@hockey_cards_gongshowFacebook - https://www.facebook.com/HockeyCardsGongshowTwitter - https://twitter.com/HCGongshowThe Hockey Cards Gongshow podcast is a production of Dollar Box Ventures LLC

Der Tag in NRW: Ist NRW ein Raumfahrtsland?; 70 Jahre alte Zeitkapsel geöffnet; Gründungsförderung durch das Land gestoppt; Wie geht man mit der asiatischen Hornisse um; Wie gut sind Schulen auf Amokläufe vorbereitet; 800 Jahre Weeze; Die nächste Generation der Greifvögel; Ausstellung zeigt den Landtag lachend; Moderation: Siham El-Maimouni. Von WDR 5.

Former Maroons star Sam Thaiday joined Dean & Sofie on 4BC Breakfast live from Sydney to showcase a bold promotional stunt featuring giant inflatable XXXX cans flying over enemy territory. He weighed in on Queensland's camp culture, addresses Cameron Munster's rumoured illness, and gives his bold prediction for a series clean sweep.See omnystudio.com/listener for privacy information.

Practice prayer. Sam and Al discuss life in recovery. Step 11 Readings from “Opening Doors Within” by Eileen Caddy and Alcoholics Anonymous Big Book. #12steps #recovery #addiction #AA #CA.

"I was allocated a more traditional river recording of serene, meandering river (with agricultural sounds). This was the final “section” available in the allocation process after all other artists had chosen. A wild card approach. "My starting point was the splitting of the field recording into 16 evenly split samples. I then created using a Roland sp404 sampler, 16 x 1 minute loops where I could sculpt and create fragments of songs and melody sections. These featured a number of sounds from esoteric spring reverb feedback generators, sampling keyboards and white noise machines. The intention at this stage was to create 16 “streams” of sound that could be played live and interwoven like the currents in a river. Repeating the process ensured further degradation of sample, source material and traditional song structure. The remaining parts were then ready to be played live and put back together. Through the process of reforming loops, samples and layered sonic ephemera, the final track took shape and dominant melody resurfaced."I had written 8 statements at the start of the process and placed them above my studio desk next to aerial views of the river section I was working with:You are the river.They are the river.The river is within us.The river is part of usThe river washes us clean.The river is us.We try and control the river.The river reflects our lives."These 8 statements became the beginning and end of the track in sonic form. The statements were fed into google translate creating a low resolution, machine like human voice. These were then sampled and manipulated before being layered into the final track which was played live and recorded in a single take."Section of the river Lech reimagined by Andy Billington. Section of the river Lech reimagined by XXXX. -------Flow is a creative exploration telling the story of a river through the power of sound. The project is a collaboration between the University of Padova and the University of Würzburg, with support from Cities and Memory. Explore the full project at https://citiesandmemory.com/flow.

https://genuinetools.com/blogs/articles/milwaukee-battery-model-numbers-explained-code-location-seriesDecode Milwaukee M12 and M18 battery model numbers with this practical guide. Learn what the 48-11-XXXX format reveals about voltage, capacity, and technology, plus how to spot counterfeits and choose the right battery for your tools. Genuine Tools City: Beaverton Address: 1500 NW Bethany Blvd. Website: https://genuinetools.com/

Enquanto a música pop se entregava aos excessos, à urgência e ao barulho, a banda inglesa The XX seguia um caminho diferente – e até bastante silencioso – com o primeiro álbum de estúdio, “XX” (2009). Aproveitando a volta do trio ao Brasil, Cleber Facchi (@cleberfacchi) e Renan Guerra (@_renanguerra) voltam no tempo para conversar sobre o disco que revelou preciosidades como "Crystalised", “Islands” e “VCR”.Gostou do podcast? Então apoie a gente em ⁠⁠⁠⁠⁠⁠⁠⁠⁠apoia.se/podcastvfsm

April is buzzing with opportunity! Companies are hiring more external suppliers than ever, thanks to rising costs for permanent staff and a shifting economy. But here's the catch - decision makers are changing how they search for experts. It's all about referrals and real expertise, not just flashy marketing or big followings.  External suppliers are in high demand due to increased costs of hiring permanent staff, particularly in the UK, Central Europe, and America. Companies are scaling with interim, freelance, or project-based resources rather than permanent hires. The biggest trend change in Q1: decision makers are shifting how they look for suppliers due to an influx of unqualified or marketing-savvy but under-skilled entrants into the B2B market. This is impacting how companies find and select external experts. Recommendations and referrals remain the primary method for organisations to find suppliers, which presents challenges for those new to the corporate market. If you're not already known or top-of-mind with decision makers, you're less likely to get referrals, emphasising the importance of strategic business development over content creation. We'll also explore the challenges posed by an influx of unqualified suppliers and strong marketers, and how that's reshaping corporate buying behavior. If you're aiming to land corporate clients without relying on cold outreach or a big following, stay tuned for practical advice and an invitation to a game-changing masterclass that promises to help you navigate these new opportunities. Key Topics Data-Driven Insights for Entrepreneurs Instead of looking at just a few sales calls, this episode analyses thousands of data points - from finding leads to closing deals. This gives entrepreneurs a proven, data-backed plan for growth that actually works in today's market. The Importance of Sales Strategy vs. Marketing Activity Don't mistake marketing for sales. While many business owners spend their time on content creation and social media, these activities have a limited impact in the B2B space. If you want to land corporate clients, you need to move beyond general marketing and build a specific sales strategy designed to close deals. Market Trends: External Suppliers in Demand Companies are shifting away from permanent hiring. Due to the high cost of recruitment and a shaky job market, businesses in the UK and abroad are now scaling up using external suppliers and freelancers. For independent consultants, this is a huge opportunity: organisations are actively seeking outside experts to fill the gaps and have the budget to pay for it.   Shift in How Companies Search for Suppliers A major trend from the start of the year is that corporate bosses are becoming much more cautious about who they hire. Because the market is flooded with 'influencers' who have big social media followings but little experience, companies are now more skeptical. While these famous names grab attention, they often take spots away from more qualified experts who simply aren't as well-known. We expect to see more of these 'influencers' moving into the business world as they look for new ways to make money.  Key Takeaways Focus on relationship-driven sales strategies and lead generation, not just content and marketing activity. Emphasise your genuine expertise and track record; companies are looking for proven external suppliers. Prepare for unpredictability in referrals and be proactive in building visibility with your target corporate clients. Leverage upcoming resources like the masterclass to stay at the forefront of industry shifts. Avoid quick-win trends and resist lowering your prices just to compete with newcomers - quality wins in corporate sales. If you're serious about landing consistent corporate clients, focus on genuine lead generation and proven skills. Stop racing to the bottom and start standing out where it counts. Want to know how?  Sign up for my masterclass on 'How to Get in Front of Corporate Clients Without Cold Outreach or Having a Big Following.' The session is based on the latest data and will help you develop lead-generation strategies that work in the current environment.  Spaces are limited - secure your place by clicking the link in the show notes now! Key Resources Mentioned in this Episode: Click below to register for the 'How to get in front of corporate clients without cold outreach or a big following' webinar on Friday 24th April at 12 Noon. https://my.demio.com/ref/OP47ZXbEtzvVOlWq Join the B2B Sales Edit https://magic.beehiiv.com/v1/988ac64b-5875-4924-9d10-50faad2aa4ad?email=%EMAIL% Episode sponsored by The Expert Services Directory: A key resource for coaches / consultants / trainers and done-for-you service providers to generate inbound leads. Access The Expert Services Directory here https://bit.ly/ExpertServicesDirectory and use code PODCAST for a special bonus. If you've enjoyed listening to XXXX check out these episodes.     Content Disclaimer The information contained above is provided for information purposes only. The contents of this article, video or audio are not intended to amount to advice and you should not rely on any of the contents of this article, video or audio. Professional advice should be obtained before taking or refraining from taking any action as a result of the contents of this article, video or audio. Jessica Lorimer disclaims all liability and responsibility arising from any reliance placed on any of the contents of this article, video or audio.  

Brand new episode! Enjoy and subscribe for more!!!     Advertise with us: https://www.podbean.com/wandeepsessionads     Donate us on PayPal:  https://www.paypal.me/iamquantom  Follow our social media: https://instagram.com/iamquantom   https://www.instagram.com/technocollectiverecords/   https://www.instagram.com/wandeepsessionofficial/   https://soundcloud.com/quantomofficial   https://www.youtube.com/channel/UC3-KJIB3z5jM4WpBI-TKoTQ   Follow our Spotify Playlist:  https://open.spotify.com/playlist/4i4M6A9QvdIAgOStjjWQPr TAG #wandeepsession on IG Follow our group on Telegram for more music:  https://t.me/wanderlustrecords   Buy new VA "Tunnel Vision" EP on Beatport: https://www.beatport.com/release/tunnel-vision-vol-i/4152894   If you want to have a guestmix in our session, just send us link with 1h of your mix (WAV) including tracklist.
 Email: tcrpublishing@outlook.com Note that WAN DEEP SESSION™ is the original and very first successful Techno show in the Czech Republic & only the #1 in your techno collection.  
 © Techno Collective Records a division of Wanderlust Records Ltd. 2017-2026 All Rights Reserved

"We'll have XXXX up the penis straws" - Suse Listen live on the Nova Player. Follow us on Facebook, Instagram & TikTokSee omnystudio.com/listener for privacy information.

Adventures Of Captain Jack (1068)

Adventures Of Captain Jack (1041)

Counterspy 4x-xx-xx The Nazi Radio Station

XXXX

XXXX

XXXX

In 2018, Andrew Davie survived a ruptured brain aneurysm and hemorrhage. Now…he recently graduated with a clinical mental health counseling degree, practices as a Licensed Graduate Professional Counselor LGPC, consults for James Mason University about brain injury assessments, and, before her passing, cared for his mother while she had ALS. He learned how to turn a terrible situation into something good with the desire to help others who may be struggling. Andrew Davie has worked in theater, finance, and education. He taught English and creative writing at the middle, high school, and college levels for students with learning difficulties and ADHD. He taught English as a second language in the United States and abroad in Hong Kong. He has written short stories and novellas, co-hosts a music review show, and volunteers.  During the second year of his recovery, when the physical part tapered off and the emotional part began, he decided to publish a book that would somehow transform his life, and it didn't. But...that's not the end of the story.     Even though his ability to experience emotional connections was blunted, the thought of being in a romantic relationship and starting a family suddenly seemed impossible. But he persevered and became a success. His story will encourage and inspire you to succeed at every challenge. Remind yourself that even moving an inch a day is still progressing!   XXXX       Read His Book Series Here From Beyond: In the aftermath of the second opium war in Southeast Asia, Declan Malcolm, the newly elected captain, must navigate the treacherous high seas. Meanwhile, Civil War veterans Ridley and Dranoff are adjusting to post-reconstruction and become mercenaries for hire. Their paths cross by chance, but soon a celebration of good fortune turns into a fight against a supernatural foe. Further Beyond: Phineas O'Hanlon has spent the last few years of his life attempting to discover the cause of the reanimation. While reading over a journal from ancient Rome, O'Hanlon is visited by two law enforcement agents. As secrets are uncovered, can O'Hanlon discover the reason behind the resurrection of the deceased and move on with his life? Remote Beyond: On a small farm, four survivors of an apocalypse fend off the undead. As Tyler and his crew adjust to the new normal, the story covers ancient Rome, Norfolk, England, in the swinging '60s, Egypt in 524 B.C., and one of the original American colonies. But will the answer to the resurrection of the undead ever be discovered?   Connect with Andrew Here INSTAGRAM FACEBOOK X   YouTube    

"Join Xavier, Eddie and Tina in this vlog as they unwrap the fresh new wrap on our latest truck and take you behind the scenes of the entire process. They break down the pros and cons of vehicle wraps, from durability and branding impact to maintenance and cost. You'll also learn the key benefits of wrapping your vehicle including increased visibility, protection for your paint, and a more professional look for your fleet. This episode is packed with helpful insights for anyone considering a wrap for their business."Download The Ultimate Checklist for Free:

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: It's World Diabetes Day and we have a LOT of news to get to! Daily oral insulin tested to prevent T1D, mothers and sons and a T1D link, stem cell updates, Tandem Android news, Omnipod's workplace campaign and more! Find out how to submit your Community Commercial Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. It's world diabetes day! It is marked every year on 14 November, the birthday of Sir Frederick Banting, who co-discovered insulin along with Charles Best in 1922.   WDD was created in 1991 by International Diabetes Federation (IDF) and the World Health Organization and became an official United Nations Day in 2006 with the passage of United Nations Resolution 61/225. There will be a ton of stuff in your feeds today and that's great! I'm going to keep this to a pretty normal in the news episode.. although I do have my own World Diabetes Day announcement – I want YOUR community commercials. You could have an ad for your event or your blog or your project right here! There's a post on the website explaining it all and I'll come back at the end of the episode and tell you more. XX The Primary Oral Insulin Trial (POInT) is the first large-scale clinical trial to test whether giving at-risk children daily oral insulin could prevent or delay type 1 diabetes (T1D). Conducted by researchers from Helmholtz Munich and the Technical University of Munich across five European countries, the study enrolled more than 1,000 children with a genetic risk for T1D. Results published in The Lancet show that while oral insulin did not prevent the development of islet autoantibodies—an early sign of diabetes—it was safe and well tolerated. Importantly, researchers found that some children who received oral insulin developed diabetes more slowly than those given a placebo, suggesting potential protective effects in certain genetic subgroups.   Further analysis revealed that the response to treatment depended on the child's insulin gene variant. Children with genetic versions that raise diabetes risk appeared to benefit, showing delayed onset of the disease, while those without the risk variant did not. These findings point toward a future of personalized prevention, where genetic screening could help identify which children might benefit most from oral insulin. Researchers will continue following the participants until age 12 to assess long-term effects. The study marks a major milestone in decades of diabetes prevention research, highlighting both the promise and complexity of developing tailored, early interventions against type 1 diabetes. XX Joint US-Chinese research looking at generating new beta cells from stomach cells. Upon turning on the "genetic switch," the human stomach cells were converted to insulin-secreting cells within the mice and resembled pancreatic beta cells with respect to gene and protein expression. Encouragingly, when those experiments were done with diabetic mice, insulin secreted from the transformed human cells helped control blood sugar levels and ameliorated diabetes. The scientists hope that a similar approach can be taken to convert cells from a patient's own stomach into insulin-secreting cells directly within the body. Importantly, additional studies are needed to address if this approach is safe and effective to be used in patients. https://www.technologynetworks.com/cell-science/news/human-stomach-cells-tweaked-to-make-insulin-406694 XX A new study in Nature Metabolism may help explain why children born to mothers with type 1 diabetes are less likely to develop the disease early in life compared to those whose fathers or siblings have it. Researchers looked at nearly 2,000 mothers and their children and found that  kids whose moms have type 1 diabetes show changes in their DNA that may actually help protect them. These aren't genetic mutations, but epigenetic changes — chemical tags that turn certain genes on or off. The study found these changes in genes tied to the immune system and type 1 diabetes risk, suggesting that a mother's condition during pregnancy can shape her child's immune response in a protective way. Scientists identified more than 500 areas of DNA where these changes occurred, many in regions that control how the body's immune system works. Most of the changes appeared to calm down the kind of overactive immune response that leads to type 1 diabetes. Researchers even created a "methylation score" to help measure this protective effect. They say the next step is to confirm these results in more diverse groups and figure out exactly how these DNA changes help prevent early diabetes. https://www.news-medical.net/news/20251110/Maternal-type-1-diabetes-may-protect-children-from-developing-the-disease.aspx XX A new study from Karolinska Institutet and Stockholm University reveals that sons born to mothers with type 1 diabetes may develop early vascular dysfunction—independently of metabolic health. The finding may help shape future strategies to prevent cardiovascular disease early in life.     Children of women with type 1 diabetes are known to be at increased risk of developing cardiovascular diseases. This new study, published in Cell Reports Medicine, is the first to show that the risk is linked to early dysfunction in blood vessel cells in sons, even before any metabolic issues arise. The team is now investigating the long-term effects of maternal diabetes, with a particular focus on why sons seem to be affected earlier than daughters. https://medicalxpress.com/news/2025-11-sons-mothers-diabetes-early-vascular.html XX A new study presented at Kidney Week 2025 has shown that the drug finn-uh-near-own  a nonsteroidal mineralocorticoid-receptor antagonist, significantly reduced albuminuria—a key marker of kidney damage—in people with type 1 diabetes (T1D) and chronic kidney disease (CKD). This is the first major breakthrough for this population in more than 30 years. Researchers found that patients taking finerenone saw a 25% average reduction in albuminuria compared to placebo, an improvement that suggests a lower long-term risk for dialysis or kidney transplant. The phase 3 FINE-ONE trial involved 242 adults with T1D and CKD, and results showed benefits as early as three months. The drug was generally well tolerated, with side effects similar to those seen in patients with type 2 diabetes, though mild hyperkalemia (high potassium levels) was slightly more common. Experts say the findings could change the way doctors treat kidney complications in type 1 diabetes, an area that hasn't seen new therapies since the early 1990s. Currently, treatment options rely on blood pressure and blood sugar management, along with renin-angiotensin system (RAS) inhibitors. Finerenone, which is already approved for type 2 diabetes-related CKD, targets overactivation of a receptor that drives kidney damage. Based on these results, Bayer plans to seek FDA approval in 2026 for use in people with T1D and CKD. Researchers and clinicians alike are calling the study "groundbreaking," noting that it opens the door to future research on how finerenone might not just slow kidney decline—but possibly prevent it altogether. https://www.medscape.com/viewarticle/finerenone-offers-hope-kidney-disease-type-1-diabetes-2025a1000uzi?form=login   XX This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system. San Diego-based Tandem revealed that it received FDA approval for the Android version of its Mobi mobile app. Clearance brings Mobi — which the company describes as the world's smallest, durable automated insulin delivery system — to more users. The pump, which pairs with Tandem's Control-IQ+ algorithm, previously worked with iOS software.   Tandem — one of the largest diabetes tech companies in the world — expects to begin a limited rollout next month, followed by full commercial availability in early 2026. This marks the latest milestone for the company, which continues to expand its offerings and widen its reach within the diabetes patient population.   We had a great interview with Tandem on our previous episode, but as I said at the time, it was coming before their earnings call. So here's an update: The company plans to submit the tubeless mobi to the fda before the end of this year.. possible approval and shipping date is hoped for by middle of 2026. Trials for their fully closed loop next-generation algorithm which we tlkaed abou ton the show should be launched in 2026 The Sigi patch pump will be developed and launched as a next-generation version of the Mobi Great job by Dr. David ? Ahn – he posted on IG after getting a message from tandem CEO John Sheridan? 1. First, the Tandem X3 *is* still absolutely in development, contrary to my speculation In yesterday's video. As many of you appropriately pointed out, there is definitely a market for a 300 unit pump, a pump with a screen, and a pump that does not require smartphone control. So from our brief chat, the sense I got that is that the X3 would be more of a refresh of the X2 with newer components, such as a USB-C connector and better memory, rather than a total redesign from the ground up. In terms of timing, all I could get was that it was "not too far distant in the future," which could mean anything I guess, but at least it's still on the way! 2. Next up, he also reassured me that they are working closely with Dexcom to support the G7 15 Day sensor within the next few months. I suspected as much, but it's always good to hear confirmation. 3. Lastly, he did confirm that Tandem is far along in developing a Caregiver/Follow app to allow the remote viewing of glucose and insulin data from a Tandem pump. He explained that it will be based on Sugarmate, the popular diabetes data dashboard app that Tandem acquired back in Jun 2020. While I don't know if every feature will make it into the Tandem caregiver app, Sugarmate is well-liked for its highly customizable dashboard and highly configurable alerts. Sugarmate even has the option to send a text message or phone call for urgent lows. Regardless, a true follow/Caregiver app will be welcomed with open arms by all caregivers and Tandem users who use Libre 3 Plus. https://time.com/7318020/worlds-top-healthtech-companies-2025/ XX Senseonics submits Eversense 365 – their year long implantable CGM for a CE mark, European Approval and expect to launch there soon. Eversense will be integrated with the sequel twist pump – again I'm hearing soon but no timeline. Intersting to note that one year inseration was approved in the US just about a year ago, so the first patients will be having their CGMs changed out – for the first time – pretty soon. https://www.drugdeliverybusiness.com/senseonics-q2-2025-sales-beat-ce-mark/ XX A confusing study out of Rutgers - these researcher say  metformin reduces some of the key benefits normally gained from regular physical activity. These include improvements in blood vessel health, physical fitness, and the body's ability to regulate blood sugar. Since 2006, doctors have typically encouraged patients with elevated blood sugar levels to combine metformin with exercise, expecting that the two proven treatments would produce stronger results together. However, the new research suggests this may not be the case. In this study, Exercise alone improved vascular insulin sensitivity, meaning blood vessels responded better to insulin and allowed more blood flow to muscles. This matters because insulin's ability to open blood vessels helps shuttle glucose out of the bloodstream and into tissues, lowering blood sugar after meals. But when metformin was added, the improvements shrank. The drug also diminished gains in aerobic fitness and reduced the positive effects on inflammation and fasting glucose. The findings don't mean people should stop taking metformin or exercising, Malin said. Instead, it raises urgent questions for doctors about how the two treatments can be combined and the need for close monitoring. Malin hopes future research will uncover strategies that preserve the benefits of both. https://scitechdaily.com/popular-diabetes-drug-metformin-may-cancel-out-exercise-benefits-study-warns/ XX XX https://www.medtechdive.com/news/Revvity-Sanofi-diabetes-test-Kihealth-seed-round/802133/   XX Dexcom recalled an Android app for its G6 glucose sensor due to a software problem that could cause the app to terminate unexpectedly. The issue could cause users to miss alarms, alerts or notifications related to estimated glucose values, according to a Food and Drug Administration database entry posted Oct. 30. The glucose sensor and the app are still available, but Dexcom required users to update the app to a new version. Dexcom began the recall on Aug. 28. The FDA designated the event as a Class 1 recall, the most serious kind. Dexcom sent a notification to customers in September about the software bug, which applies to version 1.15 of the G6 Android app. To use the app, customers must update it to a new version, according to the entry. https://www.medtechdive.com/news/dexcom-recall-g6-cgm-app/804630/ XX https://www.medscape.com/viewarticle/automated-insulin-delivery-boosts-glycemic-control-youth-2025a1000ub3 XX Tidepool partners with smart ring maker OURA.. press release says: to support a groundbreaking dataset intended to be broadly available for diabetes research, with participation limited to individuals who opt in through Tidepool.         Tidepool will pair biometric data from Oura Ring – sleep, activity, heart rate, temperature trends, and menstrual cycles – with diabetes device data, including continuous glucose monitors (CGMs) and insulin pumps. The result will provide researchers with an unprecedented dataset to accelerate the development of new clinical guidelines, next-generation diabetes technology, and personalized care models.   Recruitment is expected to launch in early 2026 through an IRB-approved study. By opting in to this study, participants consent to sharing their data with Tidepool's Big Data Donation Project, where data is de-identified and, with participant consent, shared with academics, researchers, and industry innovators to accelerate diabetes research. https://aijourn.com/tidepool-collaborates-with-oura-to-advance-inclusive-diabetes-research-through-wearables/ XX Eli Lilly launches two new clinical trials for baricitinib. These phase 3 trials will investigate whether the drug can delay T1D onset or progression and will open for recruitment soon. Baricitinib has the potential to extend the "honeymoon period" of T1D, meaning that it could preserve remaining insulin-producing beta cells earlier in disease progression. More beta cells mean better blood sugar management—and potentially reduced long-term complications. JAK inhibitors, including baricitinib, are already FDA-approved for other autoimmune diseases, such as rheumatoid arthritis, alopecia, and more. JAK signaling pathways are associated with overactive immune responses, so blocking this pathway may turn down the immune response. The phase 2 Breakthrough T1D-funded BANDIT study was key in showing that this drug is safe and effective in T1D. Importantly, baricitinib is a once-daily oral pill—meaning its use is simple and easy.   https://www.breakthrought1d.org/news-and-updates/two-new-trials-baricitinib-to-delay-t1d/ XX   Insulet is taking diabetes awareness into the workplace. Having found 79% of people with diabetes have faced bias or misunderstanding at work, the medtech giant is rolling out a range of resources intended to trigger changes in how workplaces approach the condition. Lots going on for Diabetes Awareness month.. some notables.. Insulet's "The Day Diabetes Showed up to Work" campaign. based on a survey of almost 10,000 people 79% of people with diabetes have faced bias or misunderstanding at work,.   Almost 90% of people with diabetes surveyed reported experiencing barriers at work due to their condition, and more than 40% of people with diabetes and caregivers said they have workplace-related anxiety tied to the metabolic disease. Around one-quarter of respondents reported fears that diabetes could limit opportunities or lead to workplace discrimination and judgment, and a similar proportion of people said they conceal their condition. https://www.fiercepharma.com/marketing/widespread-workplace-challenges-people-diabetes-spark-insulet-campaign XX New directive issued by the Trump administration could mean people seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity.   The guidance, issued in a cable the State Department sent to embassy and consular officials and examined by KFF Health News, directs visa officers to deem applicants ineligible to enter the U.S. for several new reasons, including age or the likelihood they might rely on public benefits.   The guidance says that such people could become a "public charge" — a potential drain on U.S. resources — because of their health issues or age.   The cable's language appears at odds with the Foreign Affairs Manual, the State Department's own handbook, which says that visa officers cannot reject an application based on "what if" scenarios, Wheeler said.   The guidance directs visa officers to develop "their own thoughts about what could lead to some sort of medical emergency or sort of medical costs in the future," he said. "That's troubling because they're not medically trained, they have no experience in this area, and they shouldn't be making projections based on their own personal knowledge or bias."   Immigrants already undergo a medical exam by a physician who's been approved by a U.S. embassy. https://www.npr.org/2025/11/12/nx-s1-5606348/immigrants-visas-health-conditions-trump-guidance XX SAN DIEGO---Nov. 14, 2025—DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today unveiled 16 new diabetes advocates to represent people living with diabetes globally as part of Dexcom's World Diabetes Day campaign. The advocates – ranging from ages six to 68, spanning various types of diabetes, and hailing from four continents and five countries – were selected from 1,000 open call submissions based on their experiences advocating for people with diabetes in their communities. While each person's experience with diabetes is unique, they share a common passion for advocacy – and use of Dexcom's glucose biosensing technology. "Through advocacy, I strive to show others, especially children and newly diagnosed patients, that diabetes is not a limitation but an opportunity to grow stronger, inspire resilience and pursue ambitious goals," said Maria Alejandra Jove Valerio, one of Dexcom's new advocates. "What began as a diagnosis at age seven has grown into a lifelong mission to uplift others." This effort represents the first time Dexcom has sourced voices from the broader diabetes community specifically for its World Diabetes Day campaign, reinforcing Dexcom's history of and commitment to giving real people with diabetes a platform to share their story on a global stage. Through engaging, editorial-style portraits and deeply personal stories, the campaign highlights each advocate's personal experience with diabetes, what misconceptions about diabetes they'd like to dispel and how they want to inspire others with diabetes to discover what they're made of. To prepare for the spotlight, the group of advocates met in Los Angeles for a World Diabetes Day photoshoot which included a surprise visit from Grammy-nominated artist, actor, producer and Dexcom Warrior Lance Bass and author, producer, actress and Stelo*Ambassador Retta. This visit offered the advocates an opportunity to exchange stories and personal perspectives on the meaning of diabetes advocacy and how they live it each day. Behind the lens at the shoot was another member of the diabetes community—photographer Tommy Lundberg who lives with Type 1 diabetes. "Directing this photoshoot was nothing short of inspiring. Each of these advocates has a unique an XX On what would have been the 100th birthday of its visionary founder Alfred E. Mann, MannKind Corporation (Nasdaq: MNKD), in partnership with Alfred E. Mann Charities and The Diabetes Link, announced the launch of the Centennial Al Mann Scholarship. The new program will distribute $100,000 in scholarship funds to support at least 10 young adult students living with diabetes as they pursue higher education in life sciences.   Launched in Diabetes Awareness Month, the scholarship program honors Alfred E. Mann's enduring legacy of innovation, philanthropy, and his lifelong commitment to improving the quality of human life through medical advancement. Deeply passionate about giving back, Mr. Mann believed that his success should continue to serve humanity long after his passing, a belief that lives on through this initiative.   Each scholarship recipient will be awarded up to $10,000, distributed in annual installments of $2,500 throughout the course of their studies. Depending on the length of their degree program, recipients may receive between two and four installments (up to the full $10,000 per student). The first awards will be made for the 2026 academic year.   "Al Mann dedicated his life to helping people with serious medical conditions live longer, healthier lives. This scholarship is a reflection of that spirit," said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. "By supporting students living with diabetes who are pursuing careers in the life sciences and adjacent fields, we're honoring Al's legacy and investing in the future of innovation and care. This program is about giving back to the community we serve and empowering the next generation to carry forward Al's mission of making a meaningful difference in people's lives."   Alfred E. Mann Charities and MannKind will partner with The Diabetes Link to launch the program to serve young adults (aged 18-22) living with either type 1 or type 2 diabetes with their higher education goals. Those eligible will include incoming freshmen and current students pursuing 2- or 4-year degrees. The application window will open in early 2026, and for those interested in receiving notifications, an early interest form is available. More information about the scholarship will be shared on thediabeteslink.org.   "We're honored to partner with MannKind to expand access to higher education for young adults with diabetes," said Manuel Hernández, Chief Executive Officer of The Diabetes Link. "At a time when the cost of college continues to rise, this scholarship helps ease the financial burden and carries forward the spirit of Al Mann, whose vision and legacy continue to inspire us."   Mr. Mann was MannKind's Chairman of the Board from 2001 until his passing in February 2016 and served as Chief Executive Officer from November 2003 until January 2015. Driven by a desire to improve lives and fill unmet medical needs, for more than six decades he founded 17 companies and developed breakthrough medical devices, including insulin pumps, cochlear implants, cardiac pacemakers and retinal prostheses. In 1997, Mr. Mann saw the potential of a dry powder insulin formulation to change the way diabetes is treated and invested nearly $1 billion to help bring Afrezza® (insulin human) Inhalation Powder to market.   About MannKind MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.   With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.   Learn more at mannkindcorp.com.   About Alfred E. Mann Charities, Inc. Alfred E. Mann Charities, Inc. became active in 2016, following the passing of the organization's benefactor, Alfred E. Mann. Throughout his life, Al was passionate about philanthropy and was dedicated to prolonging and improving the quality of human lives through innovation in the fields of healthcare and the use of medical devices. It was important to Al that his success and assets continue to better human lives even after his own passing.   Alfred E. Mann Charities, Inc. (formerly known as Alfred E. Mann Family Foundation) has similarly placed its primary focus on healthcare and medical innovation, as our organization believes this is where we can have the greatest impact on humanity and human health throughout the world. Alfred E. Mann Charities, Inc. is also dedicated to promoting arts, culture, education, and community development across Los Angeles and throughout the world in order to best serve people and this planet.   Learn more at aemanncharities.org.   About The Diabetes Link The Diabetes Link is the only national nonprofit organization dedicated to empowering young adults living with diabetes. Founded by and for young adults, The Link serves this community through peer support, leadership opportunities, and practical, evidence-based resources designed for real life. Its network of campus and community chapters, active online community, and robust Resource Hub help young adults navigate the transitions of early adulthood while managing diabetes. The organization envisions a future where every young adult living with diabetes has